Evidence map›Paper›PMID 32749928›Full record

ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2021

Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping review.

Sarah Alexander, Guy Peryer, Emma Gray, Frederik Barkhof, Jeremy Chataway

Open access · hybridAbstract readScoping Review
In one paragraph

Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Sarah AlexanderQueen Square MS Centre and Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.ORCID 0000-0002-3680-1120
Guy PeryerSchool of Health Sciences, University of East Anglia, Norwich, UK.
Emma GrayThe Multiple Sclerosis Society, London, UK.
Frederik BarkhofQueen Square MS Centre and Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK/Centre for Medical Image Computing (CMIC), Department of Medical Physics and Biomedical Engineering, University College London, London, UK/National Institute for Health Research (NIHR), Biomedical Research Centre, University College London Hospitals (UCLH), London, UK/Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.ORCID 0000-0003-3543-3706
Jeremy ChatawayQueen Square MS Centre and Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK/National Institute for Health Research (NIHR), Biomedical Research Centre, University College London Hospitals (UCLH), London, UK/MRC CTU at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
National Institute for Health Research · GBMultiple Sclerosis Society · GBNational Hospital for Neurology and Neurosurgery · GBUniversity of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wearable technology refers to any sensor worn on the person, making continuous and remote monitoring available to many people with chronic disease, including multiple sclerosis (MS). Daily monitoring seems an ideal solution either as an outcome measure or as an adjunct to support rater-based monitoring in both clinical and research settings. There has been an increase in solutions that are available, yet there is little consensus on the most appropriate solution to use in either MS research or clinical practice. We completed a scoping review (using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines) to summarise the wearable solutions available in MS, to identify those approaches that could potentially be utilised in clinical trials, by evaluating the following: scalability, cost, patient adaptability and accuracy. We identified 35 unique products that measure gait, cognition, upper limb function, activity, mood and fatigue, with most of these solutions being phone applications.

Indexed as

Multiple SclerosisWearable Electronic DevicesGaitHumansOutcome Assessment, Health CarebiosensorsmHealthmobile applicationsMultiple sclerosisremote sensing technologywearable technology

Identifiers

PMID32749928
PMCPMC8474332
OpenAlexW3047026678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.